Location: 首页  Chimie

LIU Jianrong






LIU Jianrong

Chemistry Lecturer

Courses: Advanced Chemistry and Advanced Chemistry Experiment 

Email: liujianrong2017@126.com 



Research experience:

2013-2016: UMR990 INSERM/University of Auvergne, Clermont-Ferrand, France

PhD student, Development of fluorinated radioligands for PET imaging of Phosphodiesterase 5 in brain

  • Project included mainly organic synthesis, and also radiosynthesis and biological tests

  • Collaboration with HZDR Site Leipzig (Worked twice of four weeks in Leipzig Laboratory), German

  • Collaboration with intern students (Co-supervised four students)

2012-2013: Organic Chemistry Researcher, Pharmaron Beijing Co., Ltd., Beijing, China

  • Design synthetic schemes and revise approaches in the course of research

  • Multi-steps (8-13 steps) synthesis to produce the final product in small scales (20-50 mg)

2011-2012: Internships Master in UMR990 INSERM/University of Auvergne, Clermont-Ferrand, France  

Pharmacomodulation study of a mechanical vector applied to the targeted chemotherapy

  • Synthesis of cleavable pro-drugs in hypoxic environment: Applications in metastasized melanoma


Education:

2013-2016: PhD: Pharmacochemistry, University of Auvergne, Clermont-Ferrand, France

Funded by China Scholarship Council

2010-2012: Master: Science of Medicament, University of Auvergne & University of Blaise Pascal,  Clermont-Ferrand, France

Conception, Synthesis and Pharmaceutical Development (Chemistry course)

2009-2010: French leaning, L’Alliance française de Xi’an, China

2005-2009: Bachelor of Pharmaceutical Science and Engineering, Northwest University, Xi’an, China


Approved Research Grants (Principal Investigator)

1. Project Title: Mechanism Study of Marine Natural Active Molecule Baculiferin in Anti-HIV Based on Photoaffinity Small-Molecule Probe Technology

Funding Agency: National Natural Science Foundation of China (NSFC)

Project Type: Young Scientists Fund Project

Project No.: 81803424

Period: Jan. 2019 – Dec. 2020

Funding Amount: 189,100 yuan

2. Project Title: Target Identification of Aaptamine-Type Marine Alkaloids Using Photoaffinity Labeling Technology

Funding Agency: Beijing Municipal Natural Science Foundation

Project Type: General Program

Project No.: 7202090

Period: Jan. 2020 – Dec. 2021

Funding Amount: 200,000 yuan

3. Project Title: Structure-Activity Relationship and Mechanism Study of Novel Anti-HIV Marine Alkaloid Baculiferins

Funding Agency: China Postdoctoral Science Foundation

Project Type: General Program

Project No.: 2017M620540

Period: Jan. 2017 – Dec. 2019

Funding Amount: 50,000 yuan


Publications:

Jianrong Liu,Ronan Feneux, Gauthier Roisine, Zhongrui Chen, Guide d’enseignement expérimental pour le professeur de Chimie, Shanghai, Shanghai JIAO TONG UNIVERSITY PRESS, 2024, ISBN 978-7-313-29981-9

Jianrong Liu, Ling Ma, Chang Song, Hui Xing, Shan Cen, Wenhan Lin, Anti-HIV Effects of Baculiferins Are Regulated by the Potential Target Protein DARS, ACS Chem. Biol. 2021, 16, 1377-1389

Siwen Niu, Dong Liu, Zongze Shao, Jianrong Liu, Aili Fan, Wenhan Lin, Chemical epigenetic manipulation triggers the production of sesquiterpenes from the deep-sea derived Eutypella fungus, Phytochemistry, 2021, 192, 112978

Jianrong Liu; Aurélie Maisonial-Besset; Barbara Wenzel; Damien Canitrot; Ariane Baufond;Jean-Michel Chezal; Peter Brust; Emmanuel Moreau ; Synthesis and in vitro evaluation of new fluorinated quinoline derivatives with high affinity for PDE5: Towards the development of new PETneuroimaging probes, European Journal of Medicinal Chemistry, 2017, 136: 548-560

J.R. Liu, B. Wenzel, S. Dukic-Stefanovic, R. Teodoro, F.A. Ludwig, W. Deuther-Conrad, S. Schröder, J.M. Chezal, E. Moreau, P. Brust, and A.

Maisonial-Besset; Development of a new radiofluorinated quinoline analog for PET imaging of phosphodiesterase 5 (PDE5) in brain;  

Pharmaceuticals; 2016, 9, 22; doi:10.3390/ph9020022

R. El Aissi, J.R. Liu, S. Besse, J.M. Chezal, D. Canitrot, O. Chavignon, E. Miot-Noirault, E. Moreau; Synthesis and Biological Evaluation of New Quinoxaline Derivatives of ICF01012 as Melanoma-Targeting Probes; Medicinal Chemistry Letters; 2014, 5, 468-473; dx.doi.org/10.1021/ml400468x

J.R. Liu, B. Wenzel, S. Dukic-Stefanovic, R. Teodoro, F.A. Ludwig, W. Deuther-Conrad, S. Schröder, J.M. Chezal, E. Moreau, P. Brust, and A. Maisonial-Besset; Design,  

synthesis, radiosynthesis, and biological evaluation of radiofluorinated quinoline derivatives for PET imaging of PDE5A in brain; EFMC International Symposium on  

Medicinal Chemistry; 28 August-01 September 2016, Manchester UK, Poster 082